No psychedelic drugs are legal at the federal level in the United States. However, ketamine, a dissociative drug often grouped with psychedelics, is legal for medical use. At the state level, three states — Oregon, Colorado, and Utah — have legalized psychedelics as part of their own regulated-access or pilot programs. Several other states currently […]
We’re Looking for Experts in Psychedelics If you have substantial experience working in psychedelics — and would like to share what you’ve learned with a like-minded business community — we’re now accepting speaker applications for the reMind Psychedelics Business Forum this December in Las Vegas. Whether you’re an entrepreneur, policymaker, investor, product manufacturer, or offer […]
Christi Myers is a veteran first responder with over a decade of real-world experience working in fire and emergency medicine agencies, including the Department of Defense, the Department of Justice, and San Bernadino County Fire and Sherriff Department. Drawing from her own professional and personal experiences working as an EMS first responder, in 2020, Christi […]
Joel Stanley is co-founder and CEO of Ajna Biosciences, a botanical drug development company focused on full-spectrum cannabinoid and natural psychedelic options for mental health and neurological disorders. He is also former CEO and Chairman of the Board at Charlotte’s Web, international producer of botanical CBD and other hemp-based products. Ajna is currently pursuing FDA […]
Dr. Quinn Snyder is the chief medical officer at DayTryp Health, a ketamine therapy clinic in Phoenix, Arizona, which opened in March 2023. After studying under Andrew Weil and traveling to India to study plant-based medicines, he completed his residency in Emergency Medicine at Drexel University. Quinn recently discussed the launching of DayTryp, how he […]